| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adalimumab and endoscopic dilatation in the treatment of inflammatory strictures due to Crohn's disease: A case report of a treatment-naïve patient
|
Bozzi, Rosamaria
|
|
2010
|
|
1 |
p. 10-13
4 p.
|
artikel
|
| 2 |
Adalimumab and perianal Crohn's disease: Case report
|
Principi, Mariabeatrice
|
|
2010
|
|
1 |
p. 31-33
3 p.
|
artikel
|
| 3 |
Adalimumab in a patient with steroid-dependent Crohn's disease
|
Tambasco, Rosy
|
|
2010
|
|
1 |
p. 38-39
2 p.
|
artikel
|
| 4 |
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission: A case report
|
Fiorino, Gionata
|
|
2010
|
|
1 |
p. 25-27
3 p.
|
artikel
|
| 5 |
Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn's disease: A case report
|
Caprioli, Flavio
|
|
2010
|
|
1 |
p. 14-17
4 p.
|
artikel
|
| 6 |
Butyrate in the treatment of experimental models of colitis
|
D'Argenio, G.
|
|
2007
|
|
1 |
p. 13-17
5 p.
|
artikel
|
| 7 |
Butyrate in the treatment of ulcerative colitis
|
Vernia, P.
|
|
2007
|
|
1 |
p. 27-30
4 p.
|
artikel
|
| 8 |
Butyric acid: pharmacological aspects and routes of administration
|
Spina, L.
|
|
2007
|
|
1 |
p. 7-11
5 p.
|
artikel
|
| 9 |
Clinical experience with different pegylated interferons: Is there a difference?
|
Almasio, P.L.
|
|
2009
|
|
1 |
p. 21-24
4 p.
|
artikel
|
| 10 |
Combined treatment with adalimumab and surgery in a patient with steroid-dependent Crohn's disease complicated by perianal disease
|
Renna, Sara
|
|
2010
|
|
1 |
p. 34-37
4 p.
|
artikel
|
| 11 |
Conventional drugs: the unmet needs
|
Ardizzone, S.
|
|
2008
|
|
1 |
p. 11-12
2 p.
|
artikel
|
| 12 |
Crohn's Disease: Achieving Patients' Benefits Paris, 27th October 2007
|
Ardizzone, S.
|
|
2008
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 13 |
Crohn's disease classification and its clinical usefulness
|
Prantera, C.
|
|
2008
|
|
1 |
p. 3-4
2 p.
|
artikel
|
| 14 |
Current challenges and future trends in liver transplantation
|
Rodríguez-Perálvarez, Manuel L.
|
|
2011
|
|
1 |
p. 2-5
4 p.
|
artikel
|
| 15 |
3-D structural approach on the Hansenula polymorpha-derived PEGylated interferon-α2a
|
Mueller, F.
|
|
2009
|
|
1 |
p. 9-12
4 p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
2009
|
|
1 |
p. i-
1 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
2010
|
|
1 |
p. i-
1 p.
|
artikel
|
| 18 |
Editorial Board
|
|
|
2007
|
|
1 |
p. i-
1 p.
|
artikel
|
| 19 |
Editorial Board
|
|
|
2008
|
|
1 |
p. i-
1 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
2011
|
|
1 |
p. i-
1 p.
|
artikel
|
| 21 |
Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome
|
Scarpellini, E.
|
|
2007
|
|
1 |
p. 19-22
4 p.
|
artikel
|
| 22 |
Efficacy of butyrate in the treatment of mild to moderate Crohn's disease
|
Di Sabatino, A.
|
|
2007
|
|
1 |
p. 31-35
5 p.
|
artikel
|
| 23 |
Efficacy of butyrate on rectal toxicity of radiotherapy in prostate cancer patients
|
Mete, L.S.
|
|
2007
|
|
1 |
p. 23-26
4 p.
|
artikel
|
| 24 |
Evaluation of a novel pegylated interferon alpha-2a (Reiferon Retard®) in Egyptian patients with chronic hepatitis C – genotype 4
|
Esmat, G.
|
|
2009
|
|
1 |
p. 17-19
3 p.
|
artikel
|
| 25 |
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome
|
Rendina, Maria
|
|
2011
|
|
1 |
p. 30-35
6 p.
|
artikel
|
| 26 |
Foreword
|
Gasbarrini, A.
|
|
2007
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 27 |
How do biological drugs meet treatment goals in anti-TNF naive patients, in patients with anti-TNF failure and in fistulizing patients?
|
Gionchetti, P.
|
|
2008
|
|
1 |
p. 13-14
2 p.
|
artikel
|
| 28 |
Improving patients' QoL: how the success of treatment can improve workability
|
Cottone, M.
|
|
2008
|
|
1 |
p. 17-18
2 p.
|
artikel
|
| 29 |
Interferon therapy: From cell signaling to haematological side effects
|
Goubran, H.A.
|
|
2009
|
|
1 |
p. 13-16
4 p.
|
artikel
|
| 30 |
Introduction
|
Almasio, Piero L.
|
|
2009
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 31 |
Is mucosal healing a predictor of decreased risk of Crohn's disease relapse after withdrawal of 1-year, successful adalimumab?
|
Cassinotti, Andrea
|
|
2010
|
|
1 |
p. 18-21
4 p.
|
artikel
|
| 32 |
Liver transplantation: is it a sustainable practice?
|
Filipponi, Franco
|
|
2011
|
|
1 |
p. 6-9
4 p.
|
artikel
|
| 33 |
Long-term remission with adalimumab in steroid-dependent Crohn's disease patients with multiple drug intolerances
|
Bossa, Fabrizio
|
|
2010
|
|
1 |
p. 7-9
3 p.
|
artikel
|
| 34 |
Management of HBV resistance in the post-transplant setting
|
Marzano, Alfredo
|
|
2011
|
|
1 |
p. 19-22
4 p.
|
artikel
|
| 35 |
Management of hepatitis B virus infection in the pre-transplant setting
|
Prieto, Martín
|
|
2011
|
|
1 |
p. 10-14
5 p.
|
artikel
|
| 36 |
2nd Liver Transplantation, HBV and HCV Interdisciplinary Conference
|
Esteban, Rafael
|
|
2011
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 37 |
New developments in biologics therapy: what about from the medical point of view?
|
Armuzzi, A.
|
|
2008
|
|
1 |
p. 25-26
2 p.
|
artikel
|
| 38 |
Non-invasive diagnosis of liver fibrosis in the transplant setting
|
Crespo, Gonzalo
|
|
2011
|
|
1 |
p. 23-25
3 p.
|
artikel
|
| 39 |
Opportunistic infections and anti-tumor necrosis factor antagonists in patients with IBD: prevention and diagnosis
|
Rahier, J.F.
|
|
2008
|
|
1 |
p. 23-24
2 p.
|
artikel
|
| 40 |
Optimization of hepatitis B virus prophylaxis after liver transplantation
|
De Simone, Paolo
|
|
2011
|
|
1 |
p. 15-18
4 p.
|
artikel
|
| 41 |
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease
|
Costantino, Giuseppe
|
|
2010
|
|
1 |
p. 22-24
3 p.
|
artikel
|
| 42 |
Safety of biologics – which lessons learned?
|
Ghosh, S.
|
|
2008
|
|
1 |
p. 19-20
2 p.
|
artikel
|
| 43 |
Safety of biologics: which lessons learned? The rheumatologist's point of view
|
Valesini, G.
|
|
2008
|
|
1 |
p. 21-22
2 p.
|
artikel
|
| 44 |
Spondyloarthropathy associated with Crohn's disease treated with adalimumab
|
Annunziata, Maria Laura
|
|
2010
|
|
1 |
p. 4-6
3 p.
|
artikel
|
| 45 |
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies
|
Onali, Sara
|
|
2010
|
|
1 |
p. 28-30
3 p.
|
artikel
|
| 46 |
The interferons: Past, present and future
|
Meager, A.
|
|
2009
|
|
1 |
p. 3-8
6 p.
|
artikel
|
| 47 |
The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases
|
Annunziata, Maria Laura
|
|
2010
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 48 |
Therapeutic goals in IBD
|
Campieri, M.
|
|
2008
|
|
1 |
p. 7-8
2 p.
|
artikel
|
| 49 |
The relevance of mucosal healing
|
Vecchi, M.
|
|
2008
|
|
1 |
p. 9-10
2 p.
|
artikel
|
| 50 |
The role of bacterial flora and its products in the functioning of the small intestine
|
Gasbarrini, G.
|
|
2007
|
|
1 |
p. 3-6
4 p.
|
artikel
|
| 51 |
Top down therapy in Crohn's disease
|
Ghosh, S.
|
|
2008
|
|
1 |
p. 15-16
2 p.
|
artikel
|
| 52 |
Treatment of hepatitis C in the post-transplant setting
|
Berenguer, Marina
|
|
2011
|
|
1 |
p. 26-29
4 p.
|
artikel
|
| 53 |
Updates on diagnosis: new tools? How can we measure activity?
|
Pallone, F.
|
|
2008
|
|
1 |
p. 5-6
2 p.
|
artikel
|
Tijdschrift beschrijving